Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
When To Avoid Index Investing discusses scenarios where index funds may underperform, guiding readers toward alternative strategies or active management when appropriate.
16,211 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
A U.K.-based sustainability initiative drawing U.S. CEOs is reshaping how big companies commit to the energy transiti...
Dollar General delivered strong Q4 numbers, yet the stock hasn’t taken off. This article breaks down what happened, w...
As AI workloads surge, data centers need faster, smarter networking. This piece examines the potential of a predictio...
When a veteran artist shifts from touring to studio work to vent political frustrations, finances follow. This guide ...
A discount retailer is stacking double-digit comps on top of double-digit comps. This article breaks down what that m...
Tower Semiconductor stock jumped today after a strategic move into AI networking. This article breaks down the deal, ...
Western Midstream Partners raised its quarterly distribution to $0.93 per unit, pushing the annualized payout to $3.7...
DocuSign's 2026 earnings narrative centers on ARR expansion, margin discipline, and stronger cash flow in a competiti...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Two pharma giants, two very different growth stories. This guide breaks down why Eli Lilly might be the best growth s...
York Space Systems stock jumped today as the company posted a revenue beat and improved growth indicators. This guide...